The COVID-19 pandemic ushered in an unprecedented, rapid transition to remote (web-based) health consultations, or telehealth, as providers and patients tried to minimize risk by avoiding unnecessary in-person exposures.1 Cancer providers and patients were faced with difficult decisions about which visits to transition to telehealth, postpone, or conduct in person.2-7 Although cancer survivors who have completed treatment may have less frequent visits than those in active treatment, cancer...